Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
134.38
+0.71 (0.53%)
At close: Jun 27, 2025, 4:00 PM
134.20
-0.18 (-0.13%)
After-hours: Jun 27, 2025, 7:43 PM EDT
Abbott Laboratories Revenue
Abbott Laboratories had revenue of $10.36B in the quarter ending March 31, 2025, with 3.95% growth. This brings the company's revenue in the last twelve months to $42.34B, up 5.00% year-over-year. In the year 2024, Abbott Laboratories had annual revenue of $41.95B with 4.59% growth.
Revenue (ttm)
$42.34B
Revenue Growth
+5.00%
P/S Ratio
5.44
Revenue / Employee
$371,439
Employees
114,000
Market Cap
233.80B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 41.95B | 1.84B | 4.59% |
| Dec 31, 2023 | 40.11B | -3.54B | -8.12% |
| Dec 31, 2022 | 43.65B | 578.00M | 1.34% |
| Dec 31, 2021 | 43.08B | 8.47B | 24.47% |
| Dec 31, 2020 | 34.61B | 2.70B | 8.48% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
ABT News
- 1 day ago - Abbott Hosts Conference Call for Second-Quarter Earnings - PRNewsWire
- 3 days ago - Best Dividend Kings: June 2025 - Seeking Alpha
- 7 days ago - New Research on Abbott's Healthy Food Rx Program Shows 'Food is Medicine' Approach Helps People Living With Diabetes Eat Better and Feel Healthier - PRNewsWire
- 14 days ago - Abbott Declares 406th Consecutive Quarterly Dividend - PRNewsWire
- 17 days ago - The Highest-Quality Dividend Contenders By Quality Scores - Seeking Alpha
- 21 days ago - Healthcare companies are hiring. Is it time to look for growth stocks in this beaten-down sector? - Market Watch
- 4 weeks ago - Best Dividend Aristocrats For June 2025 - Seeking Alpha
- 4 weeks ago - Abbott Receives FDA Approval for Tendyne™, First-of-Its-Kind Device to Replace the Mitral Valve Without Open-Heart Surgery - PRNewsWire